Photo taken from AACR/LinkedIn
Aug 21, 2024, 13:57
AACR – Broadening eligibility criteria for cancer clinical trials may better demonstrate how a drug will affect a real-world population
American Association for Cancer Research shared on LinkedIn:
“Broadening eligibility criteria for cancer clinical trials allows more patients to participate and may better demonstrate how a drug will affect a real-world population. Data from a recent study published in the AACR journal Clinical Cancer Research and new efforts from the FDA may help clinical researchers do this safely.”
Read further.
Source: AACR/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 24, 2025, 23:27
Feb 24, 2025, 15:25
Feb 24, 2025, 14:55
Feb 24, 2025, 14:51
Feb 24, 2025, 14:45
Feb 24, 2025, 14:22
Feb 24, 2025, 14:08
Feb 24, 2025, 14:00
Feb 24, 2025, 13:59